Table 3.
Regression coefficient, 95% CI | p value | |
---|---|---|
PVC burden %, (change from 4.0% to 17.4%) | −0.644 (−1.063, −0.225) | <.001 |
Antiarrhythmic drug use (yes:no) | −0.287 (−0.723, 0.149) | .091 |
PVC burden %a antiarrhythmic use | – | .059 |
Interpolated PVC (yes:no) | 0.070 (−0.223, 0.363) | .640 |
Polymorphic PVCs (yes:no) | −0.329 (−0.689, 0.030) | .073 |
Sinus QRS duration, msn (change from 80 to 100) | −0.031 (−0.227, 0.166) | .068 |
PVC QRS duration, msn (change from 120 to 140) | −0.191 (−0.529, 0.148) | .049 |
PVC coupling interval, msn (change from 420 to 500) | −0.201 (−0.546, 0.144) | .632 |
Age, year (change from 38 to 60) | −0.249 (−0.442, −0.056) | .018 |
Gender (female:male) | 0.116 (−0.144, 0.376) | .381 |
LVOT origin (yes:no) | 0.007 (−0.349, 0.364) | .967 |
RVOT origin (yes:no) | 0.072 (−0.253, 0.396) | .665 |
Abbreviations: LVOT, left ventricular outflow tract; PVC, premature ventricular complex; RVOT; right ventricular outflow tract.
PVC burden % antiarrhythmic use interaction.